SCHEMBL3564656

SCHEMBL3564656

CCOC(=O)c1ccc(-n2nc(C(F)(F)F)cc2OC(F)F)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.45
KDM4E B2RXH2 1/20 0.45
MAPT P10636 5/20 0.44
GAA P10253 1/20 0.44
KMT2A Q03164 1/20 0.44
TSHR P16473 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
ALOX5 P09917 1/20 0.43
PTGS1 P23219 1/20 0.43
HPGD P15428 2/20 0.43
HTT P42858 2/20 0.43
TP53 P04637 1/20 0.42
HDAC3 O15379 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC10 Q969S8 1/20 0.42
HDAC11 Q96DB2 1/20 0.42
HDAC8 Q9BY41 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29864375 0.87 TP53 (0.49) ALDH1A1KDM4EMAPTGAAKMT2A
SCHEMBL31254695 0.87 ALDH1A1 (0.47) ALDH1A1KDM4EMAPTGAAKMT2A
SCHEMBL13404460 0.86 ALDH1A1 (0.47) ALDH1A1KDM4EMAPTGAAKMT2A
SCHEMBL537426 0.82 ALDH1A1 (0.49) ALDH1A1KDM4EMAPTGAAKMT2A
SCHEMBL3556331 0.82 ORAI1 (0.54) ALDH1A1MAPTGAATSHRSMN1; SMN2
SCHEMBL2083765 0.81 ALDH1A1 (0.53) ALDH1A1KDM4EMAPTTSHRSMN1; SMN2
SCHEMBL29229235 0.78 ALDH1A1 (0.45) ALDH1A1KDM4EMAPTSMN1; SMN2ALOX5
SCHEMBL3561929 0.77 PTGS2 (0.50) ALDH1A1KDM4EPTGS1
SCHEMBL7322949 0.76 PTGS2 (0.51) ALDH1A1KDM4ETSHRPTGS1NPSR1
SCHEMBL17421894 0.75 PTGES (0.62) ALDH1A1TSHRSMN1; SMN2ALOX5PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7705029-B2 Acrylonitrile derivatives for inflammation and immune-related uses SYNTA PHARMACEUTICALS CORP. (US) 2010-04-27 US disclosed
EP-1732900-A4 ACRYLONITRILE DERIVATIVES FOR INFLAMMATION AND IMMUNE-RELATED USES SYNTA PHARMACEUTICALS CORP (US) 2007-12-12 EP disclosed
US-20070270478-A1 ACRYLONITRILE DERIVATIVES FOR INFLAMMATION AND IMMUNE-RELATED USES SYNTA PHARMACEUTICALS CORP. (US) 2007-11-22 US disclosed
US-7202232-B2 Acrylonitrile derivatives for inflammation and immune-related uses SYNTA PHARMACEUTICALS CORP. (US) 2007-04-10 US disclosed
EP-1732900-A2 ACRYLONITRILE DERIVATIVES FOR INFLAMMATION AND IMMUNE-RELATED USES Synta Pharmaceuticals Corporation (US) 2006-12-20 EP disclosed
US-20050272699-A1 Acrylonitrile derivatives for inflammation and immune-related uses SYNTA PHARMACEUTICALS CORP. 2005-12-08 US disclosed
WO-2005091752-A2 ACRYLONITRILE DERIVATIVES FOR INFLAMMATION AND IMMUNE-RELATED USES SYNTA PHARMACEUTICALS CORP. (US) 2005-10-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050272699-A1 Acrylonitrile derivatives for inflammation and immune-related uses IL1B, IL6, TLR4 ALDH1A1 472/4885KDM4E 4711/4885MAPT 643/4885
US-20070270478-A1 ACRYLONITRILE DERIVATIVES FOR INFLAMMATION AND IMMUNE-RELATED USES IL1B, IL6, TLR4 ALDH1A1 472/4885KDM4E 4711/4885MAPT 643/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.